BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 23132199)

  • 1. Effects of digital mammography uptake on downstream breast-related care among older women.
    Hubbard RA; Zhu W; Onega TL; Fishman P; Henderson LM; Tosteson AN; Buist DS
    Med Care; 2012 Dec; 50(12):1053-9. PubMed ID: 23132199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessing health care use and cost consequences of a new screening modality: the case of digital mammography.
    Henderson LM; Hubbard RA; Onega TL; Zhu W; Buist DS; Fishman P; Tosteson AN
    Med Care; 2012 Dec; 50(12):1045-52. PubMed ID: 22922432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic imaging and biopsy pathways following abnormal screen-film and digital screening mammography.
    Hubbard RA; Zhu W; Horblyuk R; Karliner L; Sprague BL; Henderson L; Lee D; Onega T; Buist DS; Sweet A
    Breast Cancer Res Treat; 2013 Apr; 138(3):879-87. PubMed ID: 23471650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can Medicare billing claims data be used to assess mammography utilization among women ages 65 and older?
    Smith-Bindman R; Quale C; Chu PW; Rosenberg R; Kerlikowske K
    Med Care; 2006 May; 44(5):463-70. PubMed ID: 16641665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of a Medicare Claims-based Algorithm for Identifying Breast Cancers Detected at Screening Mammography.
    Fenton JJ; Onega T; Zhu W; Balch S; Smith-Bindman R; Henderson L; Sprague BL; Kerlikowske K; Hubbard RA
    Med Care; 2016 Mar; 54(3):e15-22. PubMed ID: 23929404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mammography use, breast cancer stage at diagnosis, and survival among older women.
    McCarthy EP; Burns RB; Freund KM; Ash AS; Shwartz M; Marwill SL; Moskowitz MA
    J Am Geriatr Soc; 2000 Oct; 48(10):1226-33. PubMed ID: 11037009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variability of interpretive accuracy among diagnostic mammography facilities.
    Jackson SL; Taplin SH; Sickles EA; Abraham L; Barlow WE; Carney PA; Geller B; Berns EA; Cutter GR; Elmore JG
    J Natl Cancer Inst; 2009 Jun; 101(11):814-27. PubMed ID: 19470953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening mammography for women aged 40 to 49 years at average risk for breast cancer: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2007; 7(1):1-32. PubMed ID: 23074501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinguishing screening from diagnostic mammograms using Medicare claims data.
    Fenton JJ; Zhu W; Balch S; Smith-Bindman R; Fishman P; Hubbard RA
    Med Care; 2014 Jul; 52(7):e44-51. PubMed ID: 22922433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Using Medicare data to estimate the prevalence of breast cancer screening in older women: comparison of different methods to identify screening mammograms.
    Randolph WM; Mahnken JD; Goodwin JS; Freeman JL
    Health Serv Res; 2002 Dec; 37(6):1643-57. PubMed ID: 12546290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. External validation of Medicare claims codes for digital mammography and computer-aided detection.
    Fenton JJ; Zhu W; Balch S; Smith-Bindman R; Lindfors KK; Hubbard RA
    Cancer Epidemiol Biomarkers Prev; 2012 Aug; 21(8):1344-7. PubMed ID: 22695737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic Accuracy of Digital Screening Mammography With and Without Computer-Aided Detection.
    Lehman CD; Wellman RD; Buist DS; Kerlikowske K; Tosteson AN; Miglioretti DL;
    JAMA Intern Med; 2015 Nov; 175(11):1828-37. PubMed ID: 26414882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cumulative probability of false-positive recall or biopsy recommendation after 10 years of screening mammography: a cohort study.
    Hubbard RA; Kerlikowske K; Flowers CI; Yankaskas BC; Zhu W; Miglioretti DL
    Ann Intern Med; 2011 Oct; 155(8):481-92. PubMed ID: 22007042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measuring the performance of screening mammography in community practice with Medicare claims data.
    Freeman JL; Goodwin JS; Zhang D; Nattinger AB; Freeman DH
    Women Health; 2003; 37(2):1-15. PubMed ID: 12733550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Racial differences in false-positive mammogram rates: results from the ACRIN Digital Mammographic Imaging Screening Trial (DMIST).
    McCarthy AM; Yamartino P; Yang J; Bristol M; Conant EF; Armstrong K
    Med Care; 2015 Aug; 53(8):673-8. PubMed ID: 26125419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Facility characteristics do not explain higher false-positive rates in diagnostic mammography at facilities serving vulnerable women.
    Goldman LE; Walker R; Miglioretti DL; Smith-Bindman R; Kerlikowske AK;
    Med Care; 2012 Mar; 50(3):210-6. PubMed ID: 22186768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of Digital Breast Tomosynthesis Compared With Digital Mammography: Outcomes Analysis From 3 Years of Breast Cancer Screening.
    McDonald ES; Oustimov A; Weinstein SP; Synnestvedt MB; Schnall M; Conant EF
    JAMA Oncol; 2016 Jun; 2(6):737-43. PubMed ID: 26893205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Timeliness of abnormal screening and diagnostic mammography follow-up at facilities serving vulnerable women.
    Goldman LE; Walker R; Hubbard R; Kerlikowske K;
    Med Care; 2013 Apr; 51(4):307-14. PubMed ID: 23358386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors Impacting False Positive Recall in Screening Mammography.
    Honig EL; Mullen LA; Amir T; Alvin MD; Jones MK; Ambinder EB; Falomo ET; Harvey SC
    Acad Radiol; 2019 Nov; 26(11):1505-1512. PubMed ID: 30772138
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.